Breaking News, Promotions & Moves

RedShift BioAnalytics Names Tom O’Lenic as CEO

O'Lenic brings a wealth of expertise in driving business growth from start-up stages to favorable outcomes, with a strong emphasis on commercial strategy.

Author Image

By: Charlie Sternberg

Associate Editor

RedShift BioAnalytics Inc., a provider of analytical solutions for measurement of protein characterization and protein concentration used in biotherapeutic drug development and manufacturing, has appointed Tom O’Lenic as its new Chief Executive Officer (CEO). Experience With over two decades of experience in commercial leadership and management roles, O’Lenic brings a wealth of expertise in driving business growth from start-up stages to favorable outcomes, with a strong emphasi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters